Case Study: Sarah Cannon Research Institute (SCRI) achieves 94% faster document signing and $250K first-year savings with SIGNiX

Clinical Research Organization Accelerates Trials with SIGNiX

Sarah Cannon Research Institute (SCRI), a global clinical research organization running 500+ trials and working with over 1,000 physicians, needed to accelerate trial launches that were slowed by paper-based, ink-signature workflows taking 19–58 days to complete and generating high printing, courier and long‑term storage costs. To meet strict regulatory and security requirements, SCRI piloted SIGNiX’s e-signature service (PharmaDoX), seeking an FDA‑compliant, internationally valid solution.

SIGNiX deployed an independent, tamper‑proof e-signature system with flexible APIs and a simple multi‑device interface, integrating into SCRI’s workflows while meeting 21 CFR Part 11 and international standards. As a result, signing time dropped to 3–4 days (a 94% reduction), SCRI projects roughly $250,000 in first‑year savings on printing/postage/storage (with eventual enterprise savings >$500,000), removed the need for additional paper storage, and gained stronger security and global interoperability.

Sarah Cannon Research Institute (SCRI)